Vaccine Pioneer Stanley A. Plotkin, MD Joins Inovio Biomedical Corporation’s Scientific Advisory Board

SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today that Stanley A. Plotkin, MD, has agreed to join the company’s scientific advisory board.